Welcome to our dedicated page for DIH Holdings US SEC filings (Ticker: DHAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking the FDA path of a robotic rehabilitation device while decoding revenue recognition rules can make DIH Holdings US (DHAI) filings feel like a clinical trial in patience. Each 10-K hides pages of R&D spend, device adoption metrics and virtual-reality software agreements, and every 8-K announces material events that may shift the competitive landscape overnight. Stock Titan turns those dense documents into clear takeaways, so you can stop combing through footnotes and start focusing on what moves the market.
Our platform automatically ingests every DIH Holdings US quarterly earnings report 10-Q filing, proxy statement executive compensation table and 8-K material events explained update the moment EDGAR posts them. AI-powered summaries surface where product revenue grew, how clinical studies progressed and whether new regulatory hurdles emerged—understanding DIH Holdings US SEC documents with AI is finally possible. Need real-time alerts on DIH Holdings US Form 4 insider transactions? We flag each executive stock move, complete with context, so you can gauge insider confidence without refreshing EDGAR all day.
Whether you’re asking, “What does DIH report in its annual report 10-K?” or searching for “DIH Holdings US earnings report filing analysis,” the answers live here. Explore:
- DIH Holdings US insider trading Form 4 transactions and real-time notifications
- Device sales trends inside the DIH Holdings US annual report 10-K simplified
- Segment margins and backlog in each DIH Holdings US quarterly earnings report 10-Q filing
- Board pay details from the DIH Holdings US proxy statement executive compensation schedule
- Regulatory breakthroughs in DIH Holdings US 8-K material events explained
DIH Holding US, Inc. entered a common shares purchase agreement with an investor, enabling sales of up to the lesser of $22,000,000 in aggregate gross purchase price or 10,458,031 Class A common shares in a private placement. Purchases will be priced at 94% of the lowest daily VWAP over the prior three trading days including the purchase date.
As a commitment fee, the investor received 100,000 shares and a pre-funded warrant for 100,000 shares, which are to be returned if the Company’s Nasdaq Hearings Panel Appeal is not successful. DIH plans to use net proceeds for working capital and general purposes and will file a resale registration statement within 45 trading days. The agreement terminates on the first day of the month following the 36‑month anniversary of the initial registration statement’s effective date.
DIH Holding US, Inc. (DHAI) furnished an 8-K announcing its fourth quarter and fiscal year ended March 31, 2025 financial results. The company issued a press release on October 20, 2025, which is included as Exhibit 99.1.
The filing is informational, pointing investors to the press release for details. DIH Holding’s Class A Common Stock (DHAI) and Warrants (DHAIW) are listed on The Nasdaq Stock Market LLC.
DIH Holding US, Inc. (DHAI) filed its annual report detailing a global rehab robotics business focused on upper and lower extremity recovery devices and interactive motion platforms. The company completed a business combination with Aurora Technology Acquisition Corp. on February 7, 2024, but has not completed its planned reorganization to acquire Motek Group and Hocoma AG; it continues to source Motek products under an exclusive distribution agreement.
Management disclosed substantial doubt about continuing as a going concern. Cash and cash equivalents were $1.9 million as of March 31, 2025, with an accumulated deficit of $43.9 million as of March 31, 2025. Revenue is concentrated in EMEA and the Americas, and around core products—Lokomat (>45%) plus Erigo, Armeo, C‑Mill, and CAREN/GRAIL (~90% combined). On October 17, 2025, the company effected a 1‑for‑25 reverse stock split; 2,092,653 common shares were outstanding as of that date. The market value of non‑affiliate equity was $38,873,419 as of September 30, 2024.
DIH Holding US, Inc. (DHAI) enacted a one-for-twenty-five reverse stock split of its Class A common stock, effective at 5:00 p.m. Eastern Time on
The reverse split does not change the total number of authorized shares. No fractional shares were issued; holders otherwise entitled to a fraction will receive one whole share. Outstanding options and warrants were adjusted proportionately. Continental Stock Transfer & Trust Company is serving as exchange agent.
DIH HOLDING US, INC. reported that a shareholder proposal related to the "Original Debentures Securities Purchase Agreement" was presented and approved by the required majority. The filing shows multiple voting tallies with shares for, against and abstaining across recorded votes, including tallies of 20,749,300 for, 839,940 against and 1,918,276 abstentions in one recorded vote and alternative tallies of 20,752,726 for, 839,524 against and 1,915,266 abstentions in another. The document is signed by Jason Chen, Chief Executive Officer and Chairman.
Barrett Mooney, identified as a Director of DIH HOLDING US, INC. (DHAI), filed an initial Section 16 Form 3 reporting ownership details related to the issuer.
The Form 3 lists the "Date of Event Requiring Statement" as 09/02/2025 and is signed by /s/ Barrett Mooney with a signature date of 09/08/2025. The filing shows 0 shares beneficially owned of Class A Common Stock, and no derivative securities are reported on the form. The reporting person's mailing address on the form is C/O DIH HOLDING US, INC., 77 ACCORD PARK DRIVE; SUITE D-1, NORWELL, MA 02061.
FAQ
What is the current stock price of DIH Holdings US (DHAI)?
What is the market cap of DIH Holdings US (DHAI)?
